⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT February 19, 2026

ZYPREXA 5 mg überzogene Tabletten 5 mg (überzogene Tablette)

📷 Wikipedia: Olanzapine · Source
ZYPREXA 5 mg überzogene Tabletten 5 mg (überzogene Tablette)
📷 Wikipedia: Olanzapine · Source
ZYPREXA 5 mg coated tablets are temporarily unavailable due to a production delay.
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 204 days ago.
📈 Timeline
15 days in total
May 18, 2026 June 2, 2026

What is this? ZYPREXA 5 mg are coated tablets that contain the active substance olanzapine. Olanzapine is a medicine used to treat mental health conditions.

What's happening? The supply of this medicine is currently delayed because the factory cannot make it right now. It should be back in stock by June 2026.

Does this affect me? If you take this medicine in Austria, you may not be able to get it until June 2026.

What should I do? Ask your pharmacist or doctor for advice before stopping or changing your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

🚫 Parallel export ban active · ATC: N05AH03 · Reason: Verzögerung in der Freigabe des Fertigproduktes · Marketing authorisation holder: Cheplapharm Registration GmbH, Weiler Straße 5e, 79540 Lörrach, Federal Republic of Germany · Affected packs: 28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-03-26, resupply 2026-06-16]

First published
February 19, 2026
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
ZYPREXA 5 mg überzogene Tabletten 5 mg (überzogene Tablette). ZYPREXA 5 mg coated tablets are temporarily unavailable due to a production delay.
When was this alert issued?
This alert was issued on February 19, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.